1. Salata O (2004) Applications of nanoparticles in biology and medicine. J Nanobiotechnol 2:3
2. Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Cartet J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H (2005) Principles for characterizing the potential human health effects from exposure: elements of screening strategy. Part Fibre Toxicol 6:2–8
3. Hoet PHM, Brüske-Hohlfeld I, Salata OV (2004) Nanoparticles: known and unknown health risks. J Nanobiotechnol 8:1–12
4. Borm PJA, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins V, Stone W, Kreyling J, Lademann R, Krutmann J, Warheit D, Oberdorster E (2006) The potential risks for nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 14:3–11
5. Wang K, Xu JJ, Chen HY (2005) A novel glucose biosensor based on the nanoscaled cobalt phthalocyanine-glucose oxidase biocomposite. Biosens Bioelectron 20:1388–1396